Alumis (ALMS) Cash from Financing Activities (2023 - 2025)
Alumis' (ALMS) quarterly Cash from Financing Activities came in at $1.3 million in Q4 2025, up 26260.0% year-on-year from N/an in Q4 2024, and up 26260.0% on a QoQ basis from $5000.0 in Q4 2024.
Alumis (ALMS) Cash from Financing Activities (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Cash from Financing Activities data on file, last reported at $1.3 million in Q4 2025.
- On a quarterly basis, Cash from Financing Activities rose 26260.0% year-over-year to $1.3 million in Q4 2025; TTM through Dec 2025 was $236.5 million, a 51.97% decrease from a year earlier, with the FY2025 full-year figure at $2.1 million, down 99.58% from the prior year.
- Cash from Financing Activities for Q4 2025 stood at $1.3 million, up from $5000.0 in the prior quarter.
- Over the last five years, Cash from Financing Activities for ALMS reached as high as $235.2 million in Q3 2024 and fell as low as $5000.0 in Q4 2024.
- Historically, Cash from Financing Activities has averaged $74.8 million across 3 years, with a median of $29.7 million in 2023.
- On a YoY basis, Cash from Financing Activities climbed as much as 500221.28% in 2024 and fell as far as 99.98% in 2024.
- Year by year, Cash from Financing Activities stood at $29.7 million in 2023, then tumbled by 99.98% to $5000.0 in 2024, then jumped by 26260.0% to $1.3 million in 2025.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were $1.3 million in Q4 2025, $5000.0 in Q4 2024, and $235.2 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 30.14 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 68.63 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 9,311.16 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -538.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -802.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 238.74 Mn |
| 10 | Alumis | 2.41 Bn | 2.10 Bn | - | 1.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.32 Mn |
| Dec 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 235.15 Mn |
| Sep 30, 2024 | 235.15 Mn |
| Jun 30, 2024 | 128.06 Mn |
| Jun 30, 2024 | 128.06 Mn |
| Mar 31, 2024 | 129.15 Mn |
| Mar 31, 2024 | 129.15 Mn |
| Dec 31, 2023 | 29.72 Mn |
| Dec 31, 2023 | 29.72 Mn |
| Sep 30, 2023 | 47,000.00 |
| Sep 30, 2023 | 47,000.00 |